Correlation Between ABVC Biopharma and NanoViricides

Can any of the company-specific risk be diversified away by investing in both ABVC Biopharma and NanoViricides at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining ABVC Biopharma and NanoViricides into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between ABVC Biopharma and NanoViricides, you can compare the effects of market volatilities on ABVC Biopharma and NanoViricides and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in ABVC Biopharma with a short position of NanoViricides. Check out your portfolio center. Please also check ongoing floating volatility patterns of ABVC Biopharma and NanoViricides.

Diversification Opportunities for ABVC Biopharma and NanoViricides

0.15

Correlation Coefficient

ABVC Biopharma  NanoViricides

Average diversification

The 3 months correlation between ABVC and NanoViricides is 0.15. Overlapping area represents the amount of risk that can be diversified away by holding ABVC Biopharma and NanoViricides in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on NanoViricides and ABVC Biopharma is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on ABVC Biopharma are associated (or correlated) with NanoViricides. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of NanoViricides has no effect on the direction of ABVC Biopharma i.e., ABVC Biopharma and NanoViricides go up and down completely randomly.

Pair Corralation between ABVC Biopharma and NanoViricides

Given the investment horizon of 90 days ABVC Biopharma is expected to generate 2.16 times more return on investment than NanoViricides. However, ABVC Biopharma is 2.16 times more volatile than NanoViricides. It trades about 0.15 of its potential returns per unit of risk. NanoViricides is currently generating about 0.09 per unit of risk. If you would invest  136.00  in ABVC Biopharma on May 11, 2025 and sell it today you would earn a total of  134.00  from holding ABVC Biopharma or generate 98.53% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Insignificant
Accuracy	98.41%
Values	Daily Returns

ABVC Biopharma  vs.  NanoViricides

ABVC Biopharma

Risk-Adjusted Performance

Good

Compared to the overall equity markets, risk-adjusted returns on investments in ABVC Biopharma are ranked lower than 12 (%) of all global equities and portfolios over the last 90 days. In spite of rather uncertain basic indicators, ABVC Biopharma exhibited solid returns over the last few months and may actually be approaching a breakup point.

NanoViricides

Risk-Adjusted Performance

Fair

Compared to the overall equity markets, risk-adjusted returns on investments in NanoViricides are ranked lower than 6 (%) of all global equities and portfolios over the last 90 days. In spite of rather unsteady basic indicators, NanoViricides exhibited solid returns over the last few months and may actually be approaching a breakup point.

Pair Trading with ABVC Biopharma and NanoViricides

The main advantage of trading using opposite ABVC Biopharma and NanoViricides positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if ABVC Biopharma position performs unexpectedly, NanoViricides can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in NanoViricides will offset losses from the drop in NanoViricides' long position.

The idea behind ABVC Biopharma and NanoViricides pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Premium Stories module to follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope.